HomeFile

File

View Category
Antiplatelet

Dual Antiplatelet Therapy: Less Is More for Elderly Patients

A recent meta-analysis that will be published soon in JACC Intv offers evidence of benefit derived from...
solaci -
Learn More
Antiplatelet

Transulnar Access: Another Ace Up Our Sleeve Before Transfemoral Access

Transulnar access can be as safe and effective as transradial access, and it is a particularly good...
solaci -
Learn More
Acute coronary syndromes

Tips to Prevent Radial Occlusion after Catheterization

The transradial access is the preferred access site for patients undergoing acute coronary syndrome. Compared to the transfemoral access site,...
solaci -
Learn More
Chronic Ischemic cardiopathy

Surgery Seems Superior to Angioplasty in Young Patients

Long-term follow-up of patients under 50 with multivessel coronary artery disease suggests surgery outcomes are significantly better...
solaci -
Learn More
Antiplatelet

New Study Shows Ticagrelor + Aspirin Reduce Events Rate

Just when we were starting to understand how long dual antiplatelet therapy should be for our patients, JACC publishes...
solaci -
Learn More
Chronic Ischemic cardiopathy

Silent Diabetes Is the New Stealthy Enemy

One in three “nondiabetic” patients who undergo angioplasty with current drug-eluting stents have an altered glucose metabolism,...
solaci -
Learn More
Structural heart disease

Next-Day Discharge after TAVR: Is It Viable?

Next-day discharge after transfemoral transcatheter aortic valve replacement (TAVR) might be viable, with no major complications at 30 days...
solaci -
Learn More
Acute coronary syndromes

Complete Revascularization Is Beneficial in Acute MI with Cardiogenic Shock

Around half of all cases of ST-segment elevation acute myocardial infarction (STEMI) come alongside lesions in another...
solaci -
Learn More